Equillium EQ 深 滬

美股大行评级 | 花旗上调苹果、西部数据、希捷科技、超微电脑等目标价；高盛上调蔚来"买入"评级，目标价7美元

今日重点评级关注：HC Wainwright & Co.：维持艾吉纳斯"买入"评级，目标价从23美元升至30美元；富国银行：上调Q32 Bio评级至"超配"，目标价66美元

07-14 11:36

Piper Sandler Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $20

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Equillium (NASDAQ:EQ) with a Overweight rating and announces Price Target of $20.

07-13 17:38

Equillium Shareholders Approve Reverse Split and Capital Changes

Equillium ( ($EQ) ) has shared an announcement. On May 28, 2026, Equillium, Inc...

05-30 04:51

美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价

瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价

05-29 18:09

Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.

05-29 01:32

Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis

Equillium, a biotech company, will host a virtual investor event on May 27 at 11:00 AM ET, featuring Stephen Connelly Ph.D., discussing new preclinical data on AhR modulators and the relationship between AhR activation and miR-124 induction. The webinar will explore a unifying mechanism linking AhR signaling to miR-124, with implications for inflammatory disease therapies. EQ504, an investigational AhR modulator, is highlighted for its potential ...

05-20 20:05

Equillium Q1 EPS $(0.06) Misses $(0.05) Estimate

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 75 percent increase over losses of $(0.24) per share from the same

05-14 04:54

Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights

Equillium reported Q1 2026 financial results with $61.3M in cash and plans to initiate a Phase 1 study for EQ504 in mid-2026. Snehal Naik, Ph.D., was appointed Chief Development Officer, bringing extensive experience in immunology and clinical development. EQ504, a potent AhR modulator, showed promising preclinical data supporting its potential for treating ulcerative colitis and other inflammatory diseases. The company also highlighted progress ...

05-13 20:01

Lyft Unveils First Airline Loyalty Integration With United Airlines

Lyft partnered with United Airlines for the first instance of an airline loyalty program integrating directly with a rideshare platform.

04-30 01:55

Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event

04-20 20:05